OMIA:002480-9796 : Myopathy, atypical in Equus caballus (horse)

Categories: Muscle phene

Links to possible relevant human trait(s) and/or gene(s) in OMIM: 609015 (trait) , 600890 (gene) , 143450 (gene)

Mendelian trait/disorder: unknown

Disease-related: yes

Species-specific name: Atypical myopathy

Species-specific description: Sander et al. (2021): "Several thousands of severe, often letal cases of atypical myopathy (AM) caused by the ingestion of seeds and seedlings of some Acer species have been observed in horses and other equids, occurring in all age groups from the very young to the very old animals [for review see Votion et al. (2020)]. Hypoglycin A (HGA) and methylenecyclopropylglycine (MCPG) are the constituents responsible for this. Newborn foals, however, that do not yet consume green forage themselves and therefore can receive Acer toxins prenatally only via the placenta or postnatally with the milk are apparently very rarely affected by AM. ... we hypothesize that the low concentrations of active maple toxins to be expected in a foal fed with collostrum or milk will only lead to acute disease if there is a special, possibly genetically determined sensitivity." Sander et al. (2021) investigated a single foal with severe atypical myopathy and identified an "extensive loss of function of the enzyme ... long-chain enoyl-CoA hydratase (OMIM 609015, EC 4.2.1.74). The enzyme is, at least in humans, integrated into the mitochondrial trifunctional protein which also harbors the ß-hydroxy-acyl-CoA dehydrogenase and long-chain thiolase. .... Whether a genetic defect could underlie the present case would have had to be proven by appropriate genetic studies. Unfortunately, no suitable tissue was available."

Cite this entry

Nicholas, F. W., Tammen, I., & Sydney Informatics Hub. (2021). OMIA:002480-9796: Online Mendelian Inheritance in Animals (OMIA) [dataset]. https://omia.org/. https://doi.org/10.25910/2AMR-PV70

References

Note: the references are listed in reverse chronological order (from the most recent year to the earliest year), and alphabetically by first author within a year.

2024 Renaud, B., Kruse, C.J., François, A.C., Cesarini, C., van Loon, G., Palmers, K., Boemer, F., Luis, G., Gustin, P., Votion, D.M. :
Large-scale study of blood markers in equine atypical myopathy reveals subclinical poisoning and advances in diagnostic and prognostic criteria. Environ Toxicol Pharmacol 110:S1382-6689(24)00155-8:104515, 2024. Pubmed reference: 39032580. DOI: 10.1016/j.etap.2024.104515.
2021 Sander, J., Terhardt, M., Janzen, N. :
Severe inhibition of long-chain acyl-CoA enoylhydratase (EC 4.2.1.74) in a newborn foal suffering from atypical myopathy. Front Vet Sci 8:765623, 2021. Pubmed reference: 34765670. DOI: 10.3389/fvets.2021.765623.
2020 Votion, D.M., François, A.C., Kruse, C., Renaud, B., Farinelle, A., Bouquieaux, M.C., Marcillaud-Pitel, C., Gustin, P. :
Answers to the frequently asked questions regarding horse feeding and management practices to reduce the risk of atypical myopathy. Animals (Basel) 10:365, 2020. Pubmed reference: 32102384. DOI: 10.3390/ani10020365.

Edit History


  • Created by Imke Tammen2 on 24 Nov 2021
  • Changed by Imke Tammen2 on 24 Nov 2021